Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px
Organisation › Details

Pharmstandard International S.A.

Pharmstandard International S.A. - a holding company fully committed by OJSC Pharmstandard (LSE: PHST) - is aimed to make venture investments in pharmaceutical companies based in North America and Europe with strategic focus on innovative drugs with a strong potential to cover yet unmet medical needs in Russia and CIS countries. Inbio Ventures is a management company which provides professional support for drug development activities in Russia and overseas. *

 

Period Start 2010-12-22 established
  Group Pharmstandard (Group)
Products Industry venture capital
  Industry 2 pharmaceutical
     
Region Region Luxembourg (cl=5)
  Country Luxembourg
     
Basic data Employees n. a.
     
    * Document for �About Section�: Argos Therapeutics Inc.. (8/26/13). "Press Release: Argos Therapeutics Secues $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy". Durham, NC.
     
   
Record changed: 2019-04-26

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for Pharmstandard (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px




» top